Detailed Information on Publication Record

MORAVCOVA, Katarina, Marketa SOVOVA, Jaromir OZANA, Martina KARBANOVÁ, Jan KLASEK, Agnieszka Barbara KOLASINSKA and Eliska SOVOVA. Comparing the Efficacy of Digital and In-Person Weight Loss Interventions for Patients with Obesity and Glycemic Disorders: Evidence from a Randomized Non-Inferiority Trial. Nutrients. Basel: MDPI, 2024, vol. 16, No 10, p. 1-13. ISSN 2072-6643. Available from: https://dx.doi.org/10.3390/nu16101510.

Other formats: BibTeX LaTeX RIS

TY  - JOUR
ID  - 2409338
AU  - Moravcova, Katarina - Sovova, Marketa - Ozana, Jaromir - Karbanová, Martina - Klasek, Jan - Kolasinska, Agnieszka Barbara - Sovova, Eliska
PY  - 2024
TI  - Comparing the Efficacy of Digital and In-Person Weight Loss Interventions for Patients with Obesity and Glycemic Disorders: Evidence from a Randomized Non-Inferiority Trial
JF  - Nutrients
VL  - 16
IS  - 10
SP  - 1-13
EP  - 1-13
PB  - MDPI
SN  - 20726643
KW  - obesity
KW  - digital therapeutics
KW  - lifestyle intervention
KW  - diabetes mellitus type 2
KW  - insulin resistance
UR  - https://www.mdpi.com/2072-6643/16/10/1510
N2  - Digital weight loss interventions present a viable and cost-effective alternative to traditional therapy. However, further evidence is needed to establish the equal effectiveness of both approaches. This randomized controlled non-inferiority trial aimed to compare the effects of an intensive in-person weight loss intervention program with Vitadio digital therapy. One hundred patients with obesity and diagnosed with type 2 diabetes, prediabetes, or insulin resistance were enrolled and randomly assigned to one of the two treatment groups. Over a 6-month period, the control group received five in-person consultations with a physician who specialized in obesity treatment, a dietitian and/or a nutrition nurse, while the intervention group followed the digital program based on a multimodal therapeutic approach. The extent of weight loss was assessed and compared between the groups. Additionally, changes in body composition and metabolic parameters for the digital intervention group were analyzed. The study results demonstrated comparable effectiveness of both treatments for weight reduction. The positive effects of Vitadio were further evidenced by favorable changes in body composition and lipid metabolism and improved glycemic control in the intervention group. These findings suggest that Vitadio is an effective tool for assisting patients with managing obesity and preventing diabetes progression.
ER  -

Basic information
Original name	Comparing the Efficacy of Digital and In-Person Weight Loss Interventions for Patients with Obesity and Glycemic Disorders: Evidence from a Randomized Non-Inferiority Trial
Authors	MORAVCOVA, Katarina (203 Czech Republic), Marketa SOVOVA (203 Czech Republic), Jaromir OZANA (203 Czech Republic), Martina KARBANOVÁ (203 Czech Republic, belonging to the institution), Jan KLASEK (203 Czech Republic), Agnieszka Barbara KOLASINSKA (203 Czech Republic) and Eliska SOVOVA (203 Czech Republic).
Edition	Nutrients, Basel, MDPI, 2024, 2072-6643.

Other information
Original language	English
Type of outcome	Article in a journal
Field of Study	30304 Public and environmental health
Country of publisher	Switzerland
Confidentiality degree	is not subject to a state or trade secret
WWW	URL
Impact factor	Impact factor: 5.900 in 2022
Organization unit	Faculty of Medicine
Doi	http://dx.doi.org/10.3390/nu16101510
UT WoS	001231311000001
Keywords in English	obesity; digital therapeutics; lifestyle intervention; diabetes mellitus type 2; insulin resistance
Tags	14110525
Tags	International impact, Reviewed
Changed by	Changed by: Mgr. Tereza Miškechová, učo 341652. Changed: 10/6/2024 08:33.

Abstract
Digital weight loss interventions present a viable and cost-effective alternative to traditional therapy. However, further evidence is needed to establish the equal effectiveness of both approaches. This randomized controlled non-inferiority trial aimed to compare the effects of an intensive in-person weight loss intervention program with Vitadio digital therapy. One hundred patients with obesity and diagnosed with type 2 diabetes, prediabetes, or insulin resistance were enrolled and randomly assigned to one of the two treatment groups. Over a 6-month period, the control group received five in-person consultations with a physician who specialized in obesity treatment, a dietitian and/or a nutrition nurse, while the intervention group followed the digital program based on a multimodal therapeutic approach. The extent of weight loss was assessed and compared between the groups. Additionally, changes in body composition and metabolic parameters for the digital intervention group were analyzed. The study results demonstrated comparable effectiveness of both treatments for weight reduction. The positive effects of Vitadio were further evidenced by favorable changes in body composition and lipid metabolism and improved glycemic control in the intervention group. These findings suggest that Vitadio is an effective tool for assisting patients with managing obesity and preventing diabetes progression.

Abstract

Digital weight loss interventions present a viable and cost-effective alternative to traditional therapy. However, further evidence is needed to establish the equal effectiveness of both approaches. This randomized controlled non-inferiority trial aimed to compare the effects of an intensive in-person weight loss intervention program with Vitadio digital therapy. One hundred patients with obesity and diagnosed with type 2 diabetes, prediabetes, or insulin resistance were enrolled and randomly assigned to one of the two treatment groups. Over a 6-month period, the control group received five in-person consultations with a physician who specialized in obesity treatment, a dietitian and/or a nutrition nurse, while the intervention group followed the digital program based on a multimodal therapeutic approach. The extent of weight loss was assessed and compared between the groups. Additionally, changes in body composition and metabolic parameters for the digital intervention group were analyzed. The study results demonstrated comparable effectiveness of both treatments for weight reduction. The positive effects of Vitadio were further evidenced by favorable changes in body composition and lipid metabolism and improved glycemic control in the intervention group. These findings suggest that Vitadio is an effective tool for assisting patients with managing obesity and preventing diabetes progression.